Bruker Corporation (BRKR) vs Glaukos Corporation (GKOS)
- Bruker Corporation BRKR 54.80 −3.08%
- Glaukos Corporation GKOS 164.84 −0.46%
Bruker Corporation and Glaukos Corporation are both Medical Devices companies. Glaukos Corporation is the larger, with a market value of $9.8B against $8.6B — 1.1× the size. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 1.65%. Bruker Corporation has the higher net margin (−3.05% vs −30.7%) and the higher return on invested capital (−0.47% vs −26.1%). Across the 18 metrics below, Bruker Corporation leads on 11 and Glaukos Corporation on 7.
Valuation
Profitability
| Metric | BRKR | GKOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 46.42% | 79.12% | 56.01% |
| Operating margin | (0.87%) | (31.55%) | (15.03%) |
| Net margin | (3.05%) | (30.68%) | (20.40%) |
| Free cash flow margin | 2.68% | (1.99%) | (7.24%) |
| Return on equity | (5.07%) | (25.98%) | (15.32%) |
| Return on assets | (1.73%) | (19.72%) | (19.72%) |
| Return on invested capital | (0.47%) | (26.07%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack